Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Evaluation of Patients With Thyroid Disorders
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), September 2008
Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001159
  Purpose

Participants in this study will be patients diagnosed with or suspected to have a thyroid function disorder. These conditions may include: hypothyroidism, hyperthyroidism, thyroid hormone resistance, Graves' Dermopathy, and thyroid-stimulating hormone (TSH) secreting pituitary adenomas.

The main purpose of this study is to further understand the natural history, clinical presentation, and genetics of thyroid function disorders. Many of the tests performed are in the context of standard medical care that is offered to all patients with thyroid function disorders. In addition, blood and tissue samples may be taken for research and genetic studies.


Condition
Hyperthyroidism
Hypothyroidism
Pituitary Neoplasm

MedlinePlus related topics: Cancer Thyroid Diseases
Drug Information available for: Thyroid Thyrotropin
U.S. FDA Resources
Study Type: Observational
Official Title: Evaluation of Patients With Thyroid Function Disorders

Further study details as provided by National Institutes of Health Clinical Center (CC):

Study Start Date: January 1977
Detailed Description:

Patients with thyroid function abnormalities (hyperthyroidism, hypothyroidism) are studied and treated in this protocol. A limited number of patients with a personal history of signs, symptoms or laboratory studies consistent with thyroid dysfunction or a strong family history of thyroid abnormalities are also enrolled. Patients undergo routine history and physical examination, standard endocrine blood and urine tests, a standard TRH test, thyroid nuclear medicine scans, thyroidal radioiodine (RAI) or technetium (99mTc) uptake measurements, as well as X-ray, computed tomography (CT) or magnetic resonance imaging (MRI) studies or other standard diagnostic procedures, as clinically indicated. Patients will be screened for entry into other research studies.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Patients of any age with known or suspected thyroid abnormalities may be included in this study. These disorders can be broadly defined as hyper- or hypothyroid states and laboratory abnormalities.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001159

Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site

Publications:
Study ID Numbers: 770002, 77-DK-0002
Study First Received: November 3, 1999
Last Updated: October 22, 2008
ClinicalTrials.gov Identifier: NCT00001159  
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Thyroid
Pituitary Tumors
Hormone Resistance
Hyperthyroidism
Hypothyroidism
Thyroid-Stimulating Hormone Secreting Pituitary Adenomas
TSH Secreting Pituitary Adenomas
Graves' Dermopathy

Study placed in the following topic categories:
Hypothalamic Diseases
Pituitary Diseases
Endocrine System Diseases
Central Nervous System Diseases
Pituitary Neoplasms
Central Nervous System Neoplasms
Brain Diseases
Supratentorial Neoplasms
Brain Neoplasms
Hypothyroidism
Endocrinopathy
Adenoma
Thyroid Diseases
Hyperthyroidism
Nervous System Neoplasms
Endocrine Gland Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Hypothalamic Neoplasms
Nervous System Diseases

ClinicalTrials.gov processed this record on January 15, 2009